Glenmark Therapeutics Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Polyethylene Glycol 3350, Powder for Solution, 17 grams per capful, available over-the-counter (OTC). This product is comparable to the active ingredient found in MiraLAX® Powder for Solution, 17 grams, by Bayer HealthCare LLC.
Glenmark Launches OTC Polyethylene Glycol 3350 Powder to cater to individuals experiencing occasional constipation. This osmotic laxative works by drawing water into the stool, making bowel movements easier and more regular. It is unflavored, sugar-free, and grit-free, providing a smooth experience for users looking for a reliable digestive health solution.
The market for MiraLAX® Powder for Solution, 17 grams (OTC), has seen impressive growth, with annual sales reaching approximately $555.7 million. This strong market demand highlights the need for effective and high-quality laxative solutions, and Glenmark aims to fill this gap with its latest product launch.
Marc Kikuchi, President & Business Head, North America, expressed excitement about the introduction of this product, stating:
“We are excited to announce the launch of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful, addressing the growing demand for a new supplier in this category. This addition highlights our commitment to meeting market needs and providing high-quality over-the-counter solutions for our customers.”
With Glenmark Launches OTC Polyethylene Glycol 3350 Powder, the company strengthens its presence in the pharmaceutical market, ensuring consumers have access to affordable and effective health solutions. Glenmark Pharmaceuticals Ltd. is a research-driven global pharmaceutical company with a strong presence in branded, generics, and OTC segments, focusing on therapeutic areas such as respiratory, dermatology, and oncology.
The company operates 11 manufacturing facilities across four continents and serves over 80 countries. Recognized among the Top 100 biopharmaceutical companies, Glenmark continues to impact millions of lives through its innovative products and corporate social responsibility initiatives.
Consumers seeking a trusted and effective OTC laxative can now benefit from Glenmark Launches OTC Polyethylene Glycol 3350 Powder. This product is designed to meet the needs of those looking for a smooth and reliable solution for digestive health.
#InnoglidePharma #GlenmarkPharmaceuticals #OTCLaxative #ConstipationRelief #PolyethyleneGlycol3350 #MiraLAXAlternative #DigestiveHealth #PharmaceuticalLaunch #HealthcareInnovation #OverTheCounter
